From 2017 to 2021, Kouzoukas served as the chief executive of the Medicare program at the Centers for Medicare and Medicaid Services (CMS). He is a partner at the Team8 Health venture foundry, a member of the Board of Directors of Clover Health, director of Paragon Health Institute’s Medicare Initiative, and a member of the American Medical Association Digital Medicine Payment Advisory Group. Kouzoukas has deep experience in every health care sector and spanning business, law, and government. Enekwechi also serves on the board of directors at the Public Health Institute, UnityPoint Health System, and Tia, a women’s health company.ĭemetrios L.

There she led policy, management and regulatory oversight for over $1 trillion in spending across all federal health agencies and programs. In addition to her private sector experience, she spent many years in federal policy roles at the Congressional Budget Office (CBO), the Medicare Payment Advisory Commission (MedPAC) and as the head of Health Programs at the White House Office of Management and Budget (OMB) under President Obama. Enekwechi is trained in healthcare economics and outcomes research, and led IMPAQ, LLC, a company that provided research, technical assistance, and advanced analytics services for government clients which she took through its acquisition in 2020. She also brings a focus on the policy and regulatory environment which can have an outsize impact on healthcare investments. She is associate faculty at the Johns Hopkins Bloomberg School of Public Health, a Visiting Fellow for the Duke-Margolis Health Policy Center, serves on the Board of Directors of Silk Road Medical, One Mind, and is the Vice-Chair of the Alliance for Health Policy.Īdaeze Enekwechi is an operating partner at Welsh, Carson, Anderson and Stowe, an investment firm where she focuses on growth-oriented healthcare companies. Carino is a Fulbright Fellow, has served as a Visiting Fellow for the White House Office of Science and Technology Policy, and earned her doctorate in health policy from Johns Hopkins University. She began her career as an HIV case worker in Atlanta and a policy researcher in the Medicare program. Prior to joining Brunswick, Tanisha held executive roles as the first Chief Corporate Affairs Officer of Alexion, Executive Director of FasterCures/Milken Institute, led US public policy at GlaxoSmithKline, and was the head of life sciences strategic advisory services for Avalere Health. She is a corporate affairs and health policy expert who brings over 20 years of experience across multiple healthcare leadership positions in government, private, and non-profit sectors.

is a partner with the Brunswick Group, an advisory firm that helps clients navigate the interconnected financial, political, and social worlds to build trusted relationships with all their stakeholders.

Sarah dash health